CAP

AcelRx names Edwards to board of directors

Wednesday, September 28, 2011 11:55 AM

AcelRx Pharmaceuticals has named Mark G. Edwards to its board of directors. Edwards will also serve as the chairman of the audit committee.

More... »

General Electric leads $100 million fund for breast cancer challenge

Thursday, September 15, 2011 02:03 PM

General Electric joined four venture capital firms in pledging $100 million for a six-month contest to finance ideas for improving breast cancer detection, according to Bloomberg.

More... »

Roche names head of small molecules research

Wednesday, September 14, 2011 11:44 AM

Roche has named Rainer Metternich, PhD, head of small molecules research (SMR), effective immediately. He takes over from Klaus Strein, who will retire from Roche.

More... »

Dendreon to cut 500 jobs

Friday, September 9, 2011 01:42 PM

Dendreon has reported it will cut 500 jobs as it seeks to trim expenses in light of diminished sales expectations for its high-priced Provenge prostate cancer vaccine, according to Reuters.

More... »

PPD rumored to be in exclusive acquisition talks with D.C.-based private equity firm the Carlyle Group

Monday, August 22, 2011 08:02 AM

While many in the upper echelon of private equity investors have been courting CRO PPD, for now all but one have been shooed away: Washington, D.C.-based Carlyle Group.

More... »

PRA on the block, too?

Monday, August 8, 2011 08:02 AM

There was much hoopla made about PPD possibly being for sale after the Wall Street Journal published a story saying as much in mid-July. But what about its smaller competitor, PRA International?

More... »

Fuchs joins Provectus advisory board

Friday, July 15, 2011 10:48 AM

Provectus Pharmaceuticals, a development-stage oncology and dermatology biopharmaceutical company, has named Stuart Fuchs to its corporate advisory board. He is resigning from the board of directors.

More... »

INC Research completes acquisition of Kendle International

Wednesday, July 13, 2011 10:31 AM

Raleigh, N.C.-based INC Research, a therapeutically focused CRO privately held by Avista Capital Partners and Ontario Teachers’ Pension Plan, has completed the acquisition of Kendle International in an all-cash transaction with a total equity value of approximately $232 million or $15.25 per share.

More... »

Northwest Biotherapeutics receives $4.55 million investment

Friday, July 8, 2011 12:54 PM

Northwest Biotherapeutics has announced a $4.55 million equity investment by The Richard M. Schulze Family Foundation.  The sale of newly issued common stock of the company to the foundation follows the investment of $3 million by investment funds managed by Whitebox Advisors. The foundation has been focused for a number of years on game-changing medical research and treatment breakthroughs.  

More... »

AcelRx gets $20M loan

Tuesday, July 5, 2011 12:00 PM

AcelRx Pharmaceuticals has secured a $20 million loan from Hercules Technology Growth Capital, according to FierceBiotech.

More... »